Alnylam is the world’s leading RNA interference (RNAi) company.
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe’s Top Places to Work six years in a row (2015-2020), a Great Place to Work in the and Switzerland two years in a row (2019-2020) and a Science Magazine’s Top Employer two years in a row (2019-2020). Please visit for more information.
The Director, Diagnostic Lead CEMEA is a key member of the Value & Evidence Strategy group within the Global Medical Affairs team. The Diagnostic Lead CEMEA will be responsible for and will facilitate diagnostic initiatives to improve, expand, and standardize diagnostic tools critical to a patient’s diagnosis. A key function of this role will be to develop and build strong strategic partnerships with academic and clinical laboratories, enabling access to improved diagnostics and standardization of commercially available assays. This individual will work in partnership with Region and Country Medical Directors. They will be expected to build strong cross-functional relationships with colleagues in Medical Affairs including Patient Advocacy, Clinical, and Commercial, while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements. Working with Diagnostic Opinion Leaders, the Diagnostic Lead will drive education and awareness of diagnostic pathways, the appropriate use of diagnostic tools, as well as the implementation and standardization of technologies, SOPs and assay validation.
This position reports to the Head of Global Diagnostics (GDx) and will be based in either Maidenhead or Amsterdam.
Summary of Key Responsibilities
The Director/Associate Director, CEMEA Diagnostic Lead will be part of a very active team within a dynamic, fast-paced, high-profile biotechnology company. The successful candidate will possess the following capabilities and characteristics: